Streetbeat News

Products Services

DSKYF

DSNKY

MRK

Merck & Co Inc (NYSE:MRK) reported strong Q2 earnings with revenue and EPS beating estimates, driven by robust Keytruda sales. However, acquisition costs have led to a downward revision in the annual profit forecast. The company also received an FDA Complete Response Letter for a lung cancer drug application with partner Daiichi Sankyo.

Portfolio Pulse from Vandana Singh

July 30, 2024 | 12:45 pm

AMD

INTC

SOXX

SPY

AMD is set to release its Q2 earnings report, with expectations of $0.68 per share and $5.724 billion in revenue. Analysts are optimistic, citing AI momentum and server results, but note potential weaknesses in the PC, Xilinx, and Gaming segments. AMD's stock has underperformed year-to-date, falling 5.2%, while semiconductor and broader market ETFs have gained.

Portfolio Pulse from Shanthi Rexaline

July 30, 2024 | 12:42 pm

COIN

Prominent crypto trader Kaleo predicts significant growth for Bitcoin following its halving events, suggesting that the real bull market is yet to commence. Historical data shows Bitcoin's price surges occur in the year following a halving. Coinbase Institutional supports this view, noting that the current cycle is tracking previous patterns. Whale accumulation of Bitcoin is also highlighted.

Portfolio Pulse from Khyathi Dalal

July 30, 2024 | 12:39 pm

AENT

Alliance Entertainment has announced an exclusive distribution agreement with Arcade1Up for North American retail and website fulfillment of arcade and gaming products.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 12:38 pm

TEM

Tempus AI, Inc. (NASDAQ:TEM) has expanded its collaboration with Remix Therapeutics to include next-generation sequencing support for Remix's Phase I trial for REM-422. The partnership leverages Tempus' multimodal data and analytics platform to target specific cohorts such as Adenoid Cystic Carcinoma and Acute Myeloid Leukemia.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 12:37 pm

PMN

ProMIS Neurosciences presented preclinical data at AAIC 2024 supporting their Alzheimer's vaccine approach, showing strong antibody responses without pro-inflammatory T cell responses against AβO.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 12:37 pm

AAL

SABR

American Airlines has renewed its subscription to Sabre's PRISM, a corporate travel contract management solution. This renewal highlights the continued partnership between American Airlines and Sabre, which provides robust data analytics and services to optimize corporate travel contracts.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 12:36 pm

FXI

REBN

Reborn Coffee has announced a strategic partnership with China's Penglai Data Store to launch Reborn China. The collaboration will integrate advanced AI technology in coffee franchises, with plans to introduce these AI features in the U.S. upon full integration.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 12:36 pm

KOPN

Kopin Corporation (NASDAQ:KOPN) has received a $1.5 million follow-on contract to supply a near eye thermal imaging vision system for firefighter masks.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 12:35 pm

RELI

Reliance Global has announced the launch of an AI-powered Quote & Bind InsurTech solution for commercial policies, set to debut in Q4 2024 on the RELI Exchange platform. This new solution aims to enhance real-time quoting and policy binding for multiple insurance lines.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 12:35 pm